Cryolife Stock Price, News & Analysis (NYSE:CRY)

$18.25 +0.35 (+1.96 %)
(As of 02/18/2018 04:00 PM ET)
Previous Close$18.25
Today's Range$17.80 - $18.45
52-Week Range$14.02 - $24.00
Volume86,630 shs
Average Volume85,740 shs
Market Capitalization$659.56 million
P/E Ratio65.18
Dividend YieldN/A
Beta0.77

About Cryolife (NYSE:CRY)

Cryolife logoCryoLife, Inc. (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as BioGlue Surgical Adhesive, BioFoam Surgical Matrix, On-X Life Technologies Holdings, Inc. valves and surgical products, CardioGenesis cardiac laser therapy product line, PerClot and PhotoFix. PhotoFix is a pericardial patch stabilized using a dye-mediated photo-fixation process that requires no glutaraldehyde. The Preservation Services segment includes external services, such as preservation of cardiac and vascular tissues. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve SG pulmonary heart valve and the CryoPatch SG pulmonary cardiac patch, both of which are processed using CryoLife's SynerGraft technology.

Receive CRY News and Ratings via Email

Sign-up to receive the latest news and ratings for CRY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Equipment
SectorHealthcare
SymbolNYSE:CRY
CUSIP22890310
Phone+1-770-4193355

Debt

Debt-to-Equity Ratio0.29%
Current Ratio5.96%
Quick Ratio4.90%

Price-To-Earnings

Trailing P/E Ratio65.1785714285714
Forward P/E Ratio67.59
P/E GrowthN/A

Sales & Book Value

Annual Sales$180.38 million
Price / Sales3.39
Cash Flow$0.74 per share
Price / Cash24.57
Book Value$6.36 per share
Price / Book2.87

Profitability

Trailing EPS$0.28
Net Income$10.77 million
Net Margins5.28%
Return on Equity6.43%
Return on Assets4.33%

Miscellaneous

Employees665
Outstanding Shares33,460,000

Cryolife (NYSE:CRY) Frequently Asked Questions

What is Cryolife's stock symbol?

Cryolife trades on the New York Stock Exchange (NYSE) under the ticker symbol "CRY."

How were Cryolife's earnings last quarter?

Cryolife Inc (NYSE:CRY) issued its quarterly earnings results on Monday, October, 30th. The medical equipment provider reported $0.08 earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of $0.08. The medical equipment provider had revenue of $44 million for the quarter, compared to the consensus estimate of $44.60 million. Cryolife had a return on equity of 6.43% and a net margin of 5.28%. The firm's quarterly revenue was down 2.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.13 earnings per share. View Cryolife's Earnings History.

When will Cryolife make its next earnings announcement?

Cryolife is scheduled to release their next quarterly earnings announcement on Wednesday, March, 7th 2018. View Earnings Estimates for Cryolife.

Where is Cryolife's stock going? Where will Cryolife's stock price be in 2018?

3 Wall Street analysts have issued 1-year price targets for Cryolife's stock. Their predictions range from $23.50 to $26.00. On average, they expect Cryolife's share price to reach $24.83 in the next year. View Analyst Ratings for Cryolife.

What are Wall Street analysts saying about Cryolife stock?

Here are some recent quotes from research analysts about Cryolife stock:

  • 1. According to Zacks Investment Research, "CryoLife, Inc. is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries. It operates throughout the U.S. and internationally. CryoLife manufactures and distributes BioGlue Surgical Adhesive, an FDA-approved adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in Europe for use in soft tissue repair and has received additional marketing approvals in several other countries throughout the world. CryoLife's BioFoam Surgical Matrix is CE marked in Europe for use as an adjunct to hemostasis in cardiovascular surgery and on abdominal parenchymal tissues (liver and spleen) when control of bleeding by ligature or conventional methods is ineffective or impractical. CryoLife distributes PerClot, a powdered hemostat, in Europe and other select international countries. " (1/16/2018)
  • 2. Canaccord Genuity analysts commented, "We are updating our model and now include 2019 estimates. We reiterate our BUY rating and $25 price target." (1/3/2018)

Who are some of Cryolife's key competitors?

Who are Cryolife's key executives?

Cryolife's management team includes the folowing people:

  • James Patrick Mackin, Chairman of the Board, President, Chief Executive Officer (Age 50)
  • D. Ashley Lee CPA, Chief Financial Officer, Chief Operating Officer, Executive Vice President (Age 52)
  • James McDermid, Chief Human Resource Officer, Senior Vice President (Age 57)
  • Jean F. Holloway Esq., Senior Vice President, Chief Compliance Officer, General Counsel, Secretary (Age 59)
  • John Davis, Senior Vice President - Global Sales and Marketing (Age 52)
  • William R. Matthews, Senior Vice President - Operations, Regulatory, and Quality (Age 62)
  • Amy D. Horton CPA, Chief Accounting Officer, Vice President (Age 45)
  • Scott B. Capps, Vice President - Clinical Research (Age 50)
  • David C. Gale Ph.D., Vice President - Research & Development (Age 49)
  • Thomas F. Ackerman, Independent Director (Age 62)

Who owns Cryolife stock?

Cryolife's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (12.98%), Macquarie Group Ltd. (5.65%), ArrowMark Colorado Holdings LLC (2.32%), Royce & Associates LP (1.16%), William Blair Investment Management LLC (1.09%) and Thomson Horstmann & Bryant Inc. (1.01%). Company insiders that own Cryolife stock include Amy Horton, C Elkins Ronald, David Ashley Lee, David C Gale, James Benson, James P Mackin, Ronald D Mccall and Scott B Capps. View Institutional Ownership Trends for Cryolife.

Who sold Cryolife stock? Who is selling Cryolife stock?

Cryolife's stock was sold by a variety of institutional investors in the last quarter, including Driehaus Capital Management LLC, William Blair Investment Management LLC, TIAA CREF Investment Management LLC, Two Sigma Advisers LP, Royce & Associates LP and California Public Employees Retirement System. Company insiders that have sold Cryolife company stock in the last year include Amy Horton, C Elkins Ronald, David Ashley Lee, David C Gale, James Benson, James P Mackin and Scott B Capps. View Insider Buying and Selling for Cryolife.

Who bought Cryolife stock? Who is buying Cryolife stock?

Cryolife's stock was acquired by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., BlackRock Inc., Kennedy Capital Management Inc., ArrowMark Colorado Holdings LLC, Thomson Horstmann & Bryant Inc., Goldman Sachs Group Inc., NBW Capital LLC and Deutsche Bank AG. View Insider Buying and Selling for Cryolife.

How do I buy Cryolife stock?

Shares of Cryolife can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cryolife's stock price today?

One share of Cryolife stock can currently be purchased for approximately $18.25.

How big of a company is Cryolife?

Cryolife has a market capitalization of $659.56 million and generates $180.38 million in revenue each year. The medical equipment provider earns $10.77 million in net income (profit) each year or $0.28 on an earnings per share basis. Cryolife employs 665 workers across the globe.

How can I contact Cryolife?

Cryolife's mailing address is 1655 Roberts Blvd NW, KENNESAW, GA 30144-3632, United States. The medical equipment provider can be reached via phone at +1-770-4193355.


MarketBeat Community Rating for Cryolife (CRY)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  169 (Vote Outperform)
Underperform Votes:  117 (Vote Underperform)
Total Votes:  286
MarketBeat's community ratings are surveys of what our community members think about Cryolife and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cryolife (NYSE:CRY) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $24.83$23.63$23.63$22.33
Price Target Upside: 30.02% upside23.69% upside26.68% upside21.38% upside

Cryolife (NYSE:CRY) Consensus Price Target History

Price Target History for Cryolife (NYSE:CRY)

Cryolife (NYSE:CRY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/3/2018Canaccord GenuityReiterated RatingBuy$25.00LowView Rating Details
11/13/2017Northland SecuritiesReiterated RatingBuy$23.50N/AView Rating Details
10/11/2017Lake Street CapitalBoost Price TargetBuy$26.00N/AView Rating Details
2/17/2017Ladenburg Thalmann Financial ServicesUpgradeNeutral -> Buy$20.00N/AView Rating Details
7/27/2016Piper Jaffray CompaniesReiterated RatingOverweight$16.00N/AView Rating Details
(Data available from 2/18/2016 forward)

Earnings

Cryolife (NYSE:CRY) Earnings History and Estimates Chart

Earnings by Quarter for Cryolife (NYSE:CRY)

Cryolife (NYSE CRY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/7/2018$0.11N/AView Earnings Details
10/30/2017Q3 2017$0.08$0.08$44.60 million$44.00 millionViewN/AView Earnings Details
7/24/2017Q2 2017$0.10$0.12$47.02 million$47.80 millionViewN/AView Earnings Details
4/26/2017Q1 2017$0.04$0.09$44.64 million$45.10 millionViewN/AView Earnings Details
2/15/2017Q416$0.09$0.12$46.92 million$45.00 millionViewListenView Earnings Details
10/26/2016Q316$0.05$0.13$44.90 million$45.30 millionViewListenView Earnings Details
7/25/2016Q216$0.02$0.13$35.50 million$47.10 millionViewListenView Earnings Details
4/27/2016Q116$0.02$0.10$40.50 million$43.00 millionViewListenView Earnings Details
2/15/2016Q415$0.05$0.13$40.04 million$39.80 millionViewListenView Earnings Details
10/27/2015Q315$0.01$0.10$38.17 million$36.70 millionViewListenView Earnings Details
7/28/2015Q215$0.03$35.57 million$35.50 millionViewListenView Earnings Details
4/28/2015Q115$0.01($0.01)$36.55 million$33.80 millionViewListenView Earnings Details
2/17/2015Q414$0.05$0.04$37.42 million$37.20 millionViewListenView Earnings Details
10/28/2014Q314$0.05$0.08$37.70 million$37.10 millionViewListenView Earnings Details
7/24/2014Q214$0.05$0.08$35.72 million$34.69 millionViewListenView Earnings Details
4/29/2014Q114$0.07$0.04$37.30 million$35.73 millionViewListenView Earnings Details
2/20/2014Q413$0.35$0.31$34.90 million$35.50 millionViewListenView Earnings Details
10/29/2013Q313$0.05$0.12$35.51 million$36.30 millionViewListenView Earnings Details
7/25/2013Q2 2013$0.07$0.08$35.63 million$33.50 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.07$0.08$35.04 million$35.50 millionViewListenView Earnings Details
2/14/2013Q4 2012$0.05$0.08$33.58 million$32.80 millionViewListenView Earnings Details
10/30/2012Q312$0.04$0.08$32.45 million$33.40 millionViewN/AView Earnings Details
7/31/2012$0.05$0.10ViewN/AView Earnings Details
4/26/2012$0.05$0.04ViewN/AView Earnings Details
2/16/2012$0.06$0.07ViewN/AView Earnings Details
10/27/2011$0.08$0.07ViewN/AView Earnings Details
7/28/2011$0.06$0.12ViewN/AView Earnings Details
4/28/2011$0.08$0.09ViewN/AView Earnings Details
2/17/2011$0.07$0.08ViewN/AView Earnings Details
11/4/2010Q3 2010$0.09$0.09ViewN/AView Earnings Details
7/29/2010Q2 2010$0.09$0.10ViewN/AView Earnings Details
4/28/2010Q1 2010$0.08$0.07ViewN/AView Earnings Details
2/18/2010Q4 2009$0.08$0.09ViewN/AView Earnings Details
10/29/2009Q3 2009$0.07$0.07ViewN/AView Earnings Details
7/30/2009Q2 2009$0.08$0.09ViewN/AView Earnings Details
4/30/2009Q1 2009$0.06$0.07ViewN/AView Earnings Details
2/19/2009Q4 2008$0.10$0.10ViewN/AView Earnings Details
10/30/2008Q3 2008$0.08$0.12ViewN/AView Earnings Details
7/31/2008Q2 2008$0.10$0.12ViewN/AView Earnings Details
4/30/2008Q1 2008$0.09$0.10ViewN/AView Earnings Details
2/21/2008Q4 2007$0.08$0.10ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Cryolife (NYSE:CRY) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.01$0.01$0.01
Q2 20181$0.06$0.06$0.06
Q3 20181$0.02$0.02$0.02
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Cryolife (NYSE:CRY) Dividend Information

Most Recent Dividend:12/18/2015
Dividend Yield:0.00%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:0.00% (Trailing 12 Months of Earnings)
0.00% (Based on This Year's Estimates)
0.00% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Cryolife (NYSE:CRY)

Cryolife (NYSE:CRY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/22/2015quarterly$0.031.22%12/9/201512/11/201512/18/2015
7/22/2015quarterly$0.031.07%9/9/20159/11/20159/18/2015
5/21/2015quarterly$0.031.08%6/10/20156/12/20156/19/2015
2/13/2015quarterly$0.031.12%3/11/20153/13/20153/20/2015
10/23/2014quarterly$0.031.14%12/10/201412/12/201412/19/2014
7/30/2014quarterly$0.031.22%9/10/20149/12/20149/19/2014
5/22/2014quarterly$0.031.38%6/11/20146/13/20146/20/2014
2/19/2014quarterly$0.031.17%3/12/20143/14/20143/21/2014
11/21/2013quarterly$0.031.05%12/11/201312/13/201312/20/2013
8/21/2013quarterly$0.031.72%9/11/20139/13/20139/20/2013
5/28/2013quarterly$0.031.75%6/12/20136/14/20136/21/2013
2/13/2013quarterly$0.031.61%3/12/20133/14/20133/21/2013
(Data available from 1/1/2013 forward)

Insider Trades

Cryolife (NYSE CRY) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 6.00%
Institutional Ownership Percentage: 72.60%
Insider Trades by Quarter for Cryolife (NYSE:CRY)
Institutional Ownership by Quarter for Cryolife (NYSE:CRY)

Cryolife (NYSE CRY) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/15/2017C Elkins RonaldDirectorSell1,000$20.00$20,000.0099,849View SEC Filing  
11/16/2017David C GaleVPSell20,000$19.63$392,600.00View SEC Filing  
11/8/2017Amy HortonCAOSell4,000$19.00$76,000.0098,705View SEC Filing  
11/8/2017David Ashley LeeCFOSell33,190$19.00$630,610.00324,339View SEC Filing  
11/6/2017C Elkins RonaldDirectorSell1,000$19.03$19,030.00100,849View SEC Filing  
10/2/2017James BensonDirectorSell2,000$22.80$45,600.00View SEC Filing  
9/6/2017James P MackinCEOSell125,000$22.01$2,751,250.00398,399View SEC Filing  
9/5/2017C Elkins RonaldDirectorSell1,000$22.00$22,000.00101,849View SEC Filing  
9/5/2017James P MackinCEOSell43,050$22.09$950,974.50398,399View SEC Filing  
6/27/2017Amy HortonVPSell9,577$20.00$191,540.00112,282View SEC Filing  
2/22/2017Scott B CappsVPSell11,083$16.40$181,761.20128,477View SEC Filing  
7/26/2016C Elkins RonaldDirectorSell2,000$14.00$28,000.00103,586View SEC Filing  
6/1/2016Ronald D MccallDirectorSell10,000$11.56$115,600.00156,248View SEC Filing  
5/10/2016James BensonDirectorSell5,000$12.22$61,100.0065,352View SEC Filing  
4/15/2016C Elkins RonaldDirectorSell1,000$12.00$12,000.0096,852View SEC Filing  
3/7/2016C Elkins RonaldDirectorSell2,000$11.18$22,360.0097,852View SEC Filing  
3/4/2016James P MackinCEOBuy10,000$10.91$109,100.00363,933View SEC Filing  
2/19/2016Scott B CappsVPSell15,000$10.30$154,500.0091,873View SEC Filing  
2/18/2016David Ashley LeeCFOSell8,000$10.13$81,040.00243,284View SEC Filing  
12/28/2015David Ashley LeeCFOSell700$11.00$7,700.00244,269View SEC Filing  
11/30/2015David Ashley LeeCFOSell11,800$11.03$130,154.00243,969View SEC Filing  
9/15/2015James BensonDirectorSell5,839$9.65$56,346.3570,352View SEC Filing  
9/11/2015James BensonDirectorSell3,359$9.65$32,414.3576,993View SEC Filing  
2/19/2015Steven G AndersonChairmanSell30,000$10.93$327,900.00View SEC Filing  
12/9/2014Bruce G AndersonVPSell3,900$10.29$40,131.00View SEC Filing  
11/25/2014Bruce G AndersonVPSell20,211$10.11$204,333.21View SEC Filing  
11/5/2014C Elkins RonaldDirectorSell4,000$10.08$40,320.00View SEC Filing  
11/3/2014James BensonDirectorSell10,000$10.22$102,200.00View SEC Filing  
9/8/2014Bruce G AndersonVPSell10,000$10.05$100,500.00View SEC Filing  
9/2/2014Steven G AndersonChairmanSell20,000$10.08$201,600.00View SEC Filing  
8/25/2014Bruce G AndersonVPSell5,000$10.05$50,250.00View SEC Filing  
8/18/2014Bruce G AndersonVPSell10,000$10.52$105,200.00View SEC Filing  
8/14/2014David Ashley LeeCFOSell10,000$10.51$105,100.00View SEC Filing  
8/13/2014David Ashley LeeCFOSell9,881$10.51$103,849.31View SEC Filing  
8/13/2014Jeffrey W BurrisVPSell11,000$10.50$115,500.00View SEC Filing  
7/29/2014C Elkins RonaldDirectorSell2,500$9.67$24,175.00View SEC Filing  
7/28/2014Bruce G AndersonVPSell5,000$9.48$47,400.00View SEC Filing  
7/28/2014Steven G AndersonCEOSell19,477$9.52$185,421.04View SEC Filing  
6/9/2014Amy HortonCAOSell2,500$9.26$23,150.00View SEC Filing  
5/16/2014David FronkVPSell8,952$8.61$77,076.72101,528View SEC Filing  
5/13/2014Steven AndersonCEOSell30,523$9.00$274,707.001,385,810View SEC Filing  
5/6/2014Bruce AndersonVPSell16,870$8.83$148,962.1034,564View SEC Filing  
11/26/2013Jeffrey BurrisVPSell5,000$10.50$52,500.0079,099View SEC Filing  
11/11/2013Jeffrey BurrisVPSell5,000$10.00$50,000.0079,099View SEC Filing  
11/7/2013Steven AndersonCEOSell100,000$9.38$938,000.001,358,120View SEC Filing  
10/29/2013C Elkins RonaldDirectorSell2,000$9.00$18,000.00View SEC Filing  
10/29/2013Jeffrey W BurrisVPSell5,000$9.00$45,000.00View SEC Filing  
8/27/2013Bruce AndersonVPSell4,500$6.33$28,485.0036,608View SEC Filing  
8/8/2013Amy HortonCAOSell2,500$7.07$17,675.0057,574View SEC Filing  
8/1/2013Ronald D MccallDirectorSell6,000$7.10$42,600.00View SEC Filing  
6/6/2013Ronald D MccallDirectorSell4,000$6.15$24,600.00View SEC Filing  
5/31/2013C Elkins RonaldDirectorSell2,250$6.15$13,837.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Cryolife (NYSE CRY) News Headlines

Source:
DateHeadline
Cryolife Inc (CRY) Given Consensus Recommendation of "Buy" by BrokeragesCryolife Inc (CRY) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - February 13 at 11:04 AM
CryoLife Announces Release Date and Teleconference Call Details for 2017 Fourth Quarter and Year-End Financial ResultsCryoLife Announces Release Date and Teleconference Call Details for 2017 Fourth Quarter and Year-End Financial Results
www.prnewswire.com - February 12 at 5:40 PM
Cryolife (CRY) Scheduled to Post Earnings on TuesdayCryolife (CRY) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - February 6 at 3:12 AM
Ocular Therapeutix (OCUL) & Cryolife (CRY) Financial AnalysisOcular Therapeutix (OCUL) & Cryolife (CRY) Financial Analysis
www.americanbankingnews.com - February 4 at 1:08 AM
Cryolife Inc (CRY) Given Average Rating of "Buy" by AnalystsCryolife Inc (CRY) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - January 19 at 8:02 AM
Zacks Investment Research Upgrades Cryolife (CRY) to HoldZacks Investment Research Upgrades Cryolife (CRY) to Hold
www.americanbankingnews.com - January 16 at 11:46 PM
Cryolife Inc (CRY) Receives Average Rating of "Hold" from AnalystsCryolife Inc (CRY) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - December 25 at 8:06 AM
Insider Selling: Cryolife Inc (CRY) Director Sells 1,000 Shares of StockInsider Selling: Cryolife Inc (CRY) Director Sells 1,000 Shares of Stock
www.americanbankingnews.com - December 19 at 9:48 PM
CryoLife, Inc. – Value Analysis (NYSE:CRY) : December 19, 2017CryoLife, Inc. – Value Analysis (NYSE:CRY) : December 19, 2017
finance.yahoo.com - December 19 at 4:56 PM
ETFs with exposure to CryoLife, Inc. : December 18, 2017ETFs with exposure to CryoLife, Inc. : December 18, 2017
finance.yahoo.com - December 18 at 4:55 PM
CryoLife, Inc. breached its 50 day moving average in a Bullish Manner : CRY-US : December 18, 2017CryoLife, Inc. breached its 50 day moving average in a Bullish Manner : CRY-US : December 18, 2017
finance.yahoo.com - December 18 at 10:15 AM
ETFs with exposure to CryoLife, Inc. : December 7, 2017ETFs with exposure to CryoLife, Inc. : December 7, 2017
finance.yahoo.com - December 7 at 5:18 PM
CryoLife (CRY) vs. K2M Group (KTWO) Head-To-Head ContrastCryoLife (CRY) vs. K2M Group (KTWO) Head-To-Head Contrast
www.americanbankingnews.com - December 5 at 5:48 PM
BRIEF-Cryolife Says On Dec 1 Co Entered Into A Credit And Guaranty AgreementBRIEF-Cryolife Says On Dec 1 Co Entered Into A Credit And Guaranty Agreement
www.reuters.com - December 2 at 4:49 PM
CryoLife Completes Acquisition of JOTECCryoLife Completes Acquisition of JOTEC
finance.yahoo.com - December 1 at 5:14 PM
CryoLife, Inc. (CRY) Given Consensus Recommendation of "Hold" by BrokeragesCryoLife, Inc. (CRY) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - November 30 at 7:50 AM
The Asia-Pacific surgical and medical device market is expected to register a CAGR growth of 6.50% over the forecast period of 2017-2026The Asia-Pacific surgical and medical device market is expected to register a CAGR growth of 6.50% over the forecast period of 2017-2026
finance.yahoo.com - November 29 at 5:17 PM
ETFs with exposure to CryoLife, Inc. : November 27, 2017ETFs with exposure to CryoLife, Inc. : November 27, 2017
finance.yahoo.com - November 27 at 6:10 PM
Reviewing West Pharmaceutical Services (WST) & CryoLife (CRY)Reviewing West Pharmaceutical Services (WST) & CryoLife (CRY)
www.americanbankingnews.com - November 19 at 11:46 PM
CryoLife: Good Opportunity To Buy One Of The Better Small-Cap Stocks In The Med Tech SpaceCryoLife: Good Opportunity To Buy One Of The Better Small-Cap Stocks In The Med Tech Space
seekingalpha.com - November 18 at 5:12 PM
CryoLife, Inc. (CRY) to Post Q3 2018 Earnings of $0.02 Per Share, First Analysis ForecastsCryoLife, Inc. (CRY) to Post Q3 2018 Earnings of $0.02 Per Share, First Analysis Forecasts
www.americanbankingnews.com - November 18 at 12:44 AM
David C. Gale Sells 20,000 Shares of CryoLife, Inc. (CRY) StockDavid C. Gale Sells 20,000 Shares of CryoLife, Inc. (CRY) Stock
www.americanbankingnews.com - November 17 at 10:26 PM
FY2017 EPS Estimates for CryoLife, Inc. (CRY) Lowered by First AnalysisFY2017 EPS Estimates for CryoLife, Inc. (CRY) Lowered by First Analysis
www.americanbankingnews.com - November 15 at 6:58 AM
ETFs with exposure to CryoLife, Inc. : November 13, 2017ETFs with exposure to CryoLife, Inc. : November 13, 2017
finance.yahoo.com - November 13 at 9:17 PM
Amy Horton Sells 4,000 Shares of CryoLife, Inc. (CRY) StockAmy Horton Sells 4,000 Shares of CryoLife, Inc. (CRY) Stock
www.americanbankingnews.com - November 13 at 6:27 PM
Insider Selling: CryoLife, Inc. (CRY) CFO Sells 33,190 Shares of StockInsider Selling: CryoLife, Inc. (CRY) CFO Sells 33,190 Shares of Stock
www.americanbankingnews.com - November 13 at 5:15 PM
CryoLife, Inc. (CRY) Earns "Buy" Rating from Northland SecuritiesCryoLife, Inc. (CRY) Earns "Buy" Rating from Northland Securities
www.americanbankingnews.com - November 13 at 9:44 AM
CryoLife Enters Oversold Territory (CRY)CryoLife Enters Oversold Territory (CRY)
www.thestreet.com - November 10 at 5:27 PM
Insider Selling: CryoLife, Inc. (CRY) Director Sells 1,000 Shares of StockInsider Selling: CryoLife, Inc. (CRY) Director Sells 1,000 Shares of Stock
www.americanbankingnews.com - November 8 at 8:00 PM
CryoLife Announces Enrollment of First Patients in BioGlue® Clinical Trial in ChinaCryoLife Announces Enrollment of First Patients in BioGlue® Clinical Trial in China
finance.yahoo.com - November 6 at 6:50 PM
CryoLife, Inc. (CRY) Receives Average Recommendation of "Hold" from BrokeragesCryoLife, Inc. (CRY) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - November 5 at 7:38 AM
ETFs with exposure to CryoLife, Inc. : November 3, 2017ETFs with exposure to CryoLife, Inc. : November 3, 2017
finance.yahoo.com - November 4 at 7:04 AM
CryoLife, Inc. :CRY-US: Earnings Analysis: Q3, 2017 By the Numbers : November 2, 2017CryoLife, Inc. :CRY-US: Earnings Analysis: Q3, 2017 By the Numbers : November 2, 2017
finance.yahoo.com - November 2 at 6:30 PM
Edited Transcript of CRY earnings conference call or presentation 31-Oct-17 12:00pm GMTEdited Transcript of CRY earnings conference call or presentation 31-Oct-17 12:00pm GMT
finance.yahoo.com - October 31 at 11:47 PM
CryoLife, Inc. to Host Earnings CallCryoLife, Inc. to Host Earnings Call
finance.yahoo.com - October 31 at 6:45 PM
CryoLife, Inc. (CRY) Releases Quarterly  Earnings Results, Meets ExpectationsCryoLife, Inc. (CRY) Releases Quarterly Earnings Results, Meets Expectations
www.americanbankingnews.com - October 31 at 8:34 AM
EXAS Ups Outlook, NEOS Rejects PDLI Offer, Not Much To Smile About For CRYEXAS Ups Outlook, NEOS Rejects PDLI Offer, Not Much To Smile About For CRY
www.rttnews.com - October 31 at 2:27 AM
CryoLife, Inc. (CRY) Updates FY17 Earnings GuidanceCryoLife, Inc. (CRY) Updates FY17 Earnings Guidance
www.americanbankingnews.com - October 30 at 9:26 PM
BRIEF-Cryolife reports third quarter 2017 resultsBRIEF-Cryolife reports third quarter 2017 results
www.reuters.com - October 30 at 9:24 PM
CryoLife Reports Third Quarter 2017 ResultsCryoLife Reports Third Quarter 2017 Results
finance.yahoo.com - October 30 at 9:24 PM
CryoLife posts 3Q profitCryoLife posts 3Q profit
finance.yahoo.com - October 30 at 9:24 PM
FY2018 EPS Estimates for CryoLife, Inc. (CRY) Decreased by AnalystFY2018 EPS Estimates for CryoLife, Inc. (CRY) Decreased by Analyst
www.americanbankingnews.com - October 19 at 2:46 PM
First Analysis Comments on CryoLife, Inc.s Q3 2017 Earnings (CRY)First Analysis Comments on CryoLife, Inc.'s Q3 2017 Earnings (CRY)
www.americanbankingnews.com - October 18 at 9:10 AM
CryoLife, Inc. (CRY) Lowered to "Sell" at Zacks Investment ResearchCryoLife, Inc. (CRY) Lowered to "Sell" at Zacks Investment Research
www.americanbankingnews.com - October 17 at 8:26 PM
CryoLife Announces Release Date and Teleconference Call Details for 2017 Third Quarter Financial ResultsCryoLife Announces Release Date and Teleconference Call Details for 2017 Third Quarter Financial Results
finance.yahoo.com - October 17 at 6:21 PM
CryoLife, Inc. (CRY) Set to Announce Quarterly Earnings on TuesdayCryoLife, Inc. (CRY) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - October 17 at 3:44 AM
CryoLife (CRY) vs. AtriCure (ATRC) Critical SurveyCryoLife (CRY) vs. AtriCure (ATRC) Critical Survey
www.americanbankingnews.com - October 16 at 2:08 PM
CryoLife, Inc. (CRY) Price Target Increased to $26.00 by Analysts at Lake Street CapitalCryoLife, Inc. (CRY) Price Target Increased to $26.00 by Analysts at Lake Street Capital
www.americanbankingnews.com - October 15 at 10:20 PM
CryoLife, Inc. – Value Analysis (NYSE:CRY) : October 13, 2017CryoLife, Inc. – Value Analysis (NYSE:CRY) : October 13, 2017
finance.yahoo.com - October 13 at 6:09 PM
CryoLife, Inc. breached its 50 day moving average in a Bearish Manner : CRY-US : October 12, 2017CryoLife, Inc. breached its 50 day moving average in a Bearish Manner : CRY-US : October 12, 2017
finance.yahoo.com - October 12 at 6:22 PM

SEC Filings

Cryolife (NYSE:CRY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Cryolife (NYSE:CRY) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Cryolife (NYSE CRY) Stock Chart for Sunday, February, 18, 2018

Loading chart…

This page was last updated on 2/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.